Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-05

Clinical Trial Update: Bupropion and Restless Legs Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trial update for bupropion in restless legs syndrome with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bupropion (bupropion)

Snippet

Sponsor: East Tennessee State University | Conditions: Restless Legs Syndrome | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-04-05